CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (19,667)	$ (7,373)
Less: Net income from discontinued operations, net of tax		4,052
Net loss from continuing operations	(19,667)	(11,425)
Adjustments to reconcile net loss from continuing operations to net cash provided by (used in) operating activities:
Depreciation expense	8,215	8,472
Intangible asset amortization	2,672	2,647
Stock-based compensation	6,156	5,409
Amortization of debt issuance costs and discount	594	5,191
Noncash operating lease cost	1,756	1,691
Revenue assigned to factors	(1,524)	(2,601)
Deferred tax assets, net	129	250
Other	(67)	200
Changes in operating assets and liabilities of continuing operations:
Accounts receivable	(14,242)	1,013
Inventories	(4,681)	6,479
Prepaid expenses and other assets	(4,438)	398
Accounts payable	8,258	(5,138)
Accrued liabilities	(2,842)	7,270
Deferred revenue	(3,093)	(6,656)
Operating lease liabilities	(2,901)	(2,354)
Net cash provided by (used in) operating activities - continuing operations	(25,675)	10,846
Net cash used in operating activities - discontinued operations		(395)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	(25,675)	10,451
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(4,891)	(6,569)
Net cash used in investing activities - continuing operations	(4,891)	(6,569)
Net cash provided by investing activities - discontinued operations		6,616
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	(4,891)	47
CASH FLOWS FROM FINANCING ACTIVITIES:
Taxes paid related to net share settlement of vested equity awards	(1,568)	(4,017)
Proceeds from exercise of stock options and contributions to employee stock purchase plan	502	900
NET CASH USED IN FINANCING ACTIVITIES	(1,066)	(3,117)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	132	(954)
Net change in cash and cash equivalents	(31,500)	6,427
Cash and cash equivalents at beginning of period	79,221	94,624
Cash and cash equivalents at end of period	$ 47,721	$ 101,051